nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftizoxime—Nephropathy toxic—Mitomycin—urinary bladder cancer	0.0371	0.0372	CcSEcCtD
Ceftizoxime—Phlebitis—Carboplatin—urinary bladder cancer	0.0241	0.0242	CcSEcCtD
Ceftizoxime—Induration—Etoposide—urinary bladder cancer	0.0172	0.0173	CcSEcCtD
Ceftizoxime—Nephropathy toxic—Gemcitabine—urinary bladder cancer	0.0157	0.0157	CcSEcCtD
Ceftizoxime—Nephropathy toxic—Cisplatin—urinary bladder cancer	0.0146	0.0147	CcSEcCtD
Ceftizoxime—Thrombocytosis—Gemcitabine—urinary bladder cancer	0.0145	0.0145	CcSEcCtD
Ceftizoxime—Nephropathy toxic—Etoposide—urinary bladder cancer	0.0134	0.0134	CcSEcCtD
Ceftizoxime—Injection site pain—Thiotepa—urinary bladder cancer	0.0131	0.0132	CcSEcCtD
Ceftizoxime—Pancytopenia—Mitomycin—urinary bladder cancer	0.0127	0.0127	CcSEcCtD
Ceftizoxime—Anaemia—Valrubicin—urinary bladder cancer	0.0125	0.0125	CcSEcCtD
Ceftizoxime—Numbness—Fluorouracil—urinary bladder cancer	0.0107	0.0107	CcSEcCtD
Ceftizoxime—Prothrombin level increased—Epirubicin—urinary bladder cancer	0.0105	0.0105	CcSEcCtD
Ceftizoxime—Tenderness—Gemcitabine—urinary bladder cancer	0.0103	0.0104	CcSEcCtD
Ceftizoxime—Sensory loss—Fluorouracil—urinary bladder cancer	0.0102	0.0103	CcSEcCtD
Ceftizoxime—Tenderness—Fluorouracil—urinary bladder cancer	0.0102	0.0102	CcSEcCtD
Ceftizoxime—Cellulitis—Gemcitabine—urinary bladder cancer	0.00992	0.00994	CcSEcCtD
Ceftizoxime—Cellulitis—Fluorouracil—urinary bladder cancer	0.00975	0.00977	CcSEcCtD
Ceftizoxime—Prothrombin level increased—Doxorubicin—urinary bladder cancer	0.00974	0.00976	CcSEcCtD
Ceftizoxime—Tenderness—Cisplatin—urinary bladder cancer	0.00963	0.00965	CcSEcCtD
Ceftizoxime—Numbness—Etoposide—urinary bladder cancer	0.00929	0.00931	CcSEcCtD
Ceftizoxime—Cellulitis—Cisplatin—urinary bladder cancer	0.00924	0.00926	CcSEcCtD
Ceftizoxime—Sensory loss—Etoposide—urinary bladder cancer	0.00889	0.00891	CcSEcCtD
Ceftizoxime—Pain—Carboplatin—urinary bladder cancer	0.00874	0.00876	CcSEcCtD
Ceftizoxime—Body temperature increased—Valrubicin—urinary bladder cancer	0.00873	0.00875	CcSEcCtD
Ceftizoxime—Anaemia—Mitomycin—urinary bladder cancer	0.00861	0.00863	CcSEcCtD
Ceftizoxime—Cellulitis—Etoposide—urinary bladder cancer	0.00847	0.00849	CcSEcCtD
Ceftizoxime—Lactic dehydrogenase activity increased—Epirubicin—urinary bladder cancer	0.00844	0.00845	CcSEcCtD
Ceftizoxime—Leukopenia—Mitomycin—urinary bladder cancer	0.00834	0.00836	CcSEcCtD
Ceftizoxime—Body temperature increased—Carboplatin—urinary bladder cancer	0.00808	0.0081	CcSEcCtD
Ceftizoxime—Pruritus—Valrubicin—urinary bladder cancer	0.00781	0.00783	CcSEcCtD
Ceftizoxime—Lactic dehydrogenase activity increased—Doxorubicin—urinary bladder cancer	0.00781	0.00782	CcSEcCtD
Ceftizoxime—Diarrhoea—Valrubicin—urinary bladder cancer	0.00755	0.00757	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Mitomycin—urinary bladder cancer	0.00745	0.00746	CcSEcCtD
Ceftizoxime—Blood lactate dehydrogenase increased—Epirubicin—urinary bladder cancer	0.00743	0.00744	CcSEcCtD
Ceftizoxime—Phlebitis—Cisplatin—urinary bladder cancer	0.00708	0.0071	CcSEcCtD
Ceftizoxime—Vomiting—Valrubicin—urinary bladder cancer	0.00702	0.00703	CcSEcCtD
Ceftizoxime—Rash—Valrubicin—urinary bladder cancer	0.00696	0.00698	CcSEcCtD
Ceftizoxime—Dermatitis—Valrubicin—urinary bladder cancer	0.00695	0.00697	CcSEcCtD
Ceftizoxime—Thrombocytosis—Epirubicin—urinary bladder cancer	0.00694	0.00696	CcSEcCtD
Ceftizoxime—Blood lactate dehydrogenase increased—Doxorubicin—urinary bladder cancer	0.00687	0.00689	CcSEcCtD
Ceftizoxime—Haemolytic anaemia—Cisplatin—urinary bladder cancer	0.00676	0.00677	CcSEcCtD
Ceftizoxime—Nausea—Valrubicin—urinary bladder cancer	0.00656	0.00657	CcSEcCtD
Ceftizoxime—Pain—Mitomycin—urinary bladder cancer	0.0065	0.00652	CcSEcCtD
Ceftizoxime—Phlebitis—Etoposide—urinary bladder cancer	0.00649	0.0065	CcSEcCtD
Ceftizoxime—Thrombocytosis—Doxorubicin—urinary bladder cancer	0.00642	0.00644	CcSEcCtD
Ceftizoxime—Pancytopenia—Thiotepa—urinary bladder cancer	0.00639	0.0064	CcSEcCtD
Ceftizoxime—Body temperature increased—Mitomycin—urinary bladder cancer	0.00601	0.00602	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Gemcitabine—urinary bladder cancer	0.0059	0.00591	CcSEcCtD
Ceftizoxime—Agranulocytosis—Thiotepa—urinary bladder cancer	0.0056	0.00561	CcSEcCtD
Ceftizoxime—Eosinophilia—Fluorouracil—urinary bladder cancer	0.00551	0.00552	CcSEcCtD
Ceftizoxime—Haemoglobin—Thiotepa—urinary bladder cancer	0.00541	0.00542	CcSEcCtD
Ceftizoxime—Haemorrhage—Thiotepa—urinary bladder cancer	0.00538	0.00539	CcSEcCtD
Ceftizoxime—Pancytopenia—Gemcitabine—urinary bladder cancer	0.00537	0.00538	CcSEcCtD
Ceftizoxime—Neutropenia—Gemcitabine—urinary bladder cancer	0.00529	0.0053	CcSEcCtD
Ceftizoxime—Injection site pain—Epirubicin—urinary bladder cancer	0.00529	0.0053	CcSEcCtD
Ceftizoxime—Pancytopenia—Fluorouracil—urinary bladder cancer	0.00528	0.00529	CcSEcCtD
Ceftizoxime—Diarrhoea—Mitomycin—urinary bladder cancer	0.0052	0.00521	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Etoposide—urinary bladder cancer	0.00503	0.00504	CcSEcCtD
Ceftizoxime—Pancytopenia—Cisplatin—urinary bladder cancer	0.00501	0.00502	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Gemcitabine—urinary bladder cancer	0.005	0.00501	CcSEcCtD
Ceftizoxime—Injection site pain—Doxorubicin—urinary bladder cancer	0.00489	0.0049	CcSEcCtD
Ceftizoxime—Vomiting—Mitomycin—urinary bladder cancer	0.00484	0.00485	CcSEcCtD
Ceftizoxime—Rash—Mitomycin—urinary bladder cancer	0.0048	0.00481	CcSEcCtD
Ceftizoxime—Dermatitis—Mitomycin—urinary bladder cancer	0.00479	0.0048	CcSEcCtD
Ceftizoxime—Cellulitis—Epirubicin—urinary bladder cancer	0.00475	0.00476	CcSEcCtD
Ceftizoxime—Agranulocytosis—Gemcitabine—urinary bladder cancer	0.00471	0.00472	CcSEcCtD
Ceftizoxime—Agranulocytosis—Fluorouracil—urinary bladder cancer	0.00463	0.00464	CcSEcCtD
Ceftizoxime—Vaginal inflammation—Methotrexate—urinary bladder cancer	0.00461	0.00462	CcSEcCtD
Ceftizoxime—Pancytopenia—Etoposide—urinary bladder cancer	0.00459	0.0046	CcSEcCtD
Ceftizoxime—Haemoglobin—Gemcitabine—urinary bladder cancer	0.00455	0.00456	CcSEcCtD
Ceftizoxime—Haemorrhage—Gemcitabine—urinary bladder cancer	0.00453	0.00454	CcSEcCtD
Ceftizoxime—Neutropenia—Etoposide—urinary bladder cancer	0.00452	0.00453	CcSEcCtD
Ceftizoxime—Nausea—Mitomycin—urinary bladder cancer	0.00452	0.00453	CcSEcCtD
Ceftizoxime—Haemoglobin—Fluorouracil—urinary bladder cancer	0.00448	0.00448	CcSEcCtD
Ceftizoxime—Haemorrhage—Fluorouracil—urinary bladder cancer	0.00445	0.00446	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Fluorouracil—urinary bladder cancer	0.00443	0.00444	CcSEcCtD
Ceftizoxime—Cellulitis—Doxorubicin—urinary bladder cancer	0.00439	0.0044	CcSEcCtD
Ceftizoxime—Vaginal infection—Methotrexate—urinary bladder cancer	0.00436	0.00436	CcSEcCtD
Ceftizoxime—Anaemia—Thiotepa—urinary bladder cancer	0.00433	0.00434	CcSEcCtD
Ceftizoxime—Aplastic anaemia—Methotrexate—urinary bladder cancer	0.00433	0.00434	CcSEcCtD
Ceftizoxime—Vaginal inflammation—Epirubicin—urinary bladder cancer	0.00432	0.00433	CcSEcCtD
Ceftizoxime—Erythema multiforme—Gemcitabine—urinary bladder cancer	0.00428	0.00429	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Etoposide—urinary bladder cancer	0.00427	0.00428	CcSEcCtD
Ceftizoxime—Leukopenia—Thiotepa—urinary bladder cancer	0.0042	0.0042	CcSEcCtD
Ceftizoxime—Vaginal infection—Epirubicin—urinary bladder cancer	0.00408	0.00408	CcSEcCtD
Ceftizoxime—Convulsion—Thiotepa—urinary bladder cancer	0.00406	0.00407	CcSEcCtD
Ceftizoxime—Aplastic anaemia—Epirubicin—urinary bladder cancer	0.00405	0.00406	CcSEcCtD
Ceftizoxime—Agranulocytosis—Etoposide—urinary bladder cancer	0.00402	0.00403	CcSEcCtD
Ceftizoxime—Vaginal inflammation—Doxorubicin—urinary bladder cancer	0.00399	0.004	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Etoposide—urinary bladder cancer	0.00385	0.00386	CcSEcCtD
Ceftizoxime—Vaginal infection—Doxorubicin—urinary bladder cancer	0.00377	0.00378	CcSEcCtD
Ceftizoxime—Aplastic anaemia—Doxorubicin—urinary bladder cancer	0.00375	0.00376	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Thiotepa—urinary bladder cancer	0.00375	0.00375	CcSEcCtD
Ceftizoxime—Erythema multiforme—Etoposide—urinary bladder cancer	0.00366	0.00366	CcSEcCtD
Ceftizoxime—Anaemia—Gemcitabine—urinary bladder cancer	0.00364	0.00365	CcSEcCtD
Ceftizoxime—Phlebitis—Epirubicin—urinary bladder cancer	0.00364	0.00364	CcSEcCtD
Ceftizoxime—Anaemia—Fluorouracil—urinary bladder cancer	0.00358	0.00359	CcSEcCtD
Ceftizoxime—Leukopenia—Gemcitabine—urinary bladder cancer	0.00353	0.00354	CcSEcCtD
Ceftizoxime—Leukopenia—Fluorouracil—urinary bladder cancer	0.00347	0.00348	CcSEcCtD
Ceftizoxime—Paraesthesia—Thiotepa—urinary bladder cancer	0.00343	0.00344	CcSEcCtD
Ceftizoxime—Anaemia—Cisplatin—urinary bladder cancer	0.0034	0.0034	CcSEcCtD
Ceftizoxime—Phlebitis—Doxorubicin—urinary bladder cancer	0.00337	0.00337	CcSEcCtD
Ceftizoxime—Convulsion—Fluorouracil—urinary bladder cancer	0.00336	0.00337	CcSEcCtD
Ceftizoxime—Leukopenia—Cisplatin—urinary bladder cancer	0.00329	0.0033	CcSEcCtD
Ceftizoxime—Pain—Thiotepa—urinary bladder cancer	0.00327	0.00328	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.00322	0.00322	CcSEcCtD
Ceftizoxime—Convulsion—Cisplatin—urinary bladder cancer	0.00318	0.00319	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.00316	0.00317	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.00315	0.00316	CcSEcCtD
Ceftizoxime—Anaemia—Etoposide—urinary bladder cancer	0.00311	0.00312	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.0031	0.0031	CcSEcCtD
Ceftizoxime—Body temperature increased—Thiotepa—urinary bladder cancer	0.00302	0.00303	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Methotrexate—urinary bladder cancer	0.00302	0.00302	CcSEcCtD
Ceftizoxime—Leukopenia—Etoposide—urinary bladder cancer	0.00301	0.00302	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.003	0.00301	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.00294	0.00294	CcSEcCtD
Ceftizoxime—Convulsion—Etoposide—urinary bladder cancer	0.00292	0.00292	CcSEcCtD
Ceftizoxime—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00289	0.0029	CcSEcCtD
Ceftizoxime—Eosinophilia—Methotrexate—urinary bladder cancer	0.00287	0.00287	CcSEcCtD
Ceftizoxime—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00284	0.00285	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Epirubicin—urinary bladder cancer	0.00282	0.00283	CcSEcCtD
Ceftizoxime—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00282	0.00282	CcSEcCtD
Ceftizoxime—Pain—Gemcitabine—urinary bladder cancer	0.00275	0.00276	CcSEcCtD
Ceftizoxime—Pancytopenia—Methotrexate—urinary bladder cancer	0.00275	0.00275	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Etoposide—urinary bladder cancer	0.00275	0.00275	CcSEcCtD
Ceftizoxime—Neutropenia—Methotrexate—urinary bladder cancer	0.00271	0.00271	CcSEcCtD
Ceftizoxime—Pruritus—Thiotepa—urinary bladder cancer	0.00271	0.00271	CcSEcCtD
Ceftizoxime—Pain—Fluorouracil—urinary bladder cancer	0.00271	0.00271	CcSEcCtD
Ceftizoxime—Paraesthesia—Cisplatin—urinary bladder cancer	0.00269	0.0027	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Etoposide—urinary bladder cancer	0.00269	0.0027	CcSEcCtD
Ceftizoxime—Eosinophilia—Epirubicin—urinary bladder cancer	0.00268	0.00269	CcSEcCtD
Ceftizoxime—Diarrhoea—Thiotepa—urinary bladder cancer	0.00262	0.00262	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.00261	0.00262	CcSEcCtD
Ceftizoxime—Pancytopenia—Epirubicin—urinary bladder cancer	0.00257	0.00258	CcSEcCtD
Ceftizoxime—Pain—Cisplatin—urinary bladder cancer	0.00256	0.00257	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.00256	0.00256	CcSEcCtD
Ceftizoxime—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00254	0.00255	CcSEcCtD
Ceftizoxime—Neutropenia—Epirubicin—urinary bladder cancer	0.00253	0.00254	CcSEcCtD
Ceftizoxime—Body temperature increased—Fluorouracil—urinary bladder cancer	0.0025	0.00251	CcSEcCtD
Ceftizoxime—Eosinophilia—Doxorubicin—urinary bladder cancer	0.00248	0.00249	CcSEcCtD
Ceftizoxime—Paraesthesia—Etoposide—urinary bladder cancer	0.00247	0.00247	CcSEcCtD
Ceftizoxime—Vomiting—Thiotepa—urinary bladder cancer	0.00243	0.00244	CcSEcCtD
Ceftizoxime—Rash—Thiotepa—urinary bladder cancer	0.00241	0.00242	CcSEcCtD
Ceftizoxime—Dermatitis—Thiotepa—urinary bladder cancer	0.00241	0.00241	CcSEcCtD
Ceftizoxime—Agranulocytosis—Methotrexate—urinary bladder cancer	0.00241	0.00241	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.00239	0.0024	CcSEcCtD
Ceftizoxime—Pancytopenia—Doxorubicin—urinary bladder cancer	0.00238	0.00238	CcSEcCtD
Ceftizoxime—Body temperature increased—Cisplatin—urinary bladder cancer	0.00237	0.00238	CcSEcCtD
Ceftizoxime—Pain—Etoposide—urinary bladder cancer	0.00235	0.00235	CcSEcCtD
Ceftizoxime—Neutropenia—Doxorubicin—urinary bladder cancer	0.00234	0.00235	CcSEcCtD
Ceftizoxime—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00233	0.00234	CcSEcCtD
Ceftizoxime—Haemoglobin—Methotrexate—urinary bladder cancer	0.00233	0.00233	CcSEcCtD
Ceftizoxime—Haemorrhage—Methotrexate—urinary bladder cancer	0.00232	0.00232	CcSEcCtD
Ceftizoxime—Pruritus—Gemcitabine—urinary bladder cancer	0.00228	0.00228	CcSEcCtD
Ceftizoxime—Nausea—Thiotepa—urinary bladder cancer	0.00227	0.00228	CcSEcCtD
Ceftizoxime—Agranulocytosis—Epirubicin—urinary bladder cancer	0.00225	0.00226	CcSEcCtD
Ceftizoxime—Pruritus—Fluorouracil—urinary bladder cancer	0.00224	0.00224	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.00222	0.00222	CcSEcCtD
Ceftizoxime—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00221	0.00221	CcSEcCtD
Ceftizoxime—Diarrhoea—Gemcitabine—urinary bladder cancer	0.0022	0.00221	CcSEcCtD
Ceftizoxime—Erythema multiforme—Methotrexate—urinary bladder cancer	0.00219	0.00219	CcSEcCtD
Ceftizoxime—Haemoglobin—Epirubicin—urinary bladder cancer	0.00218	0.00218	CcSEcCtD
Ceftizoxime—Body temperature increased—Etoposide—urinary bladder cancer	0.00217	0.00218	CcSEcCtD
Ceftizoxime—Haemorrhage—Epirubicin—urinary bladder cancer	0.00217	0.00217	CcSEcCtD
Ceftizoxime—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00216	0.00217	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.00216	0.00216	CcSEcCtD
Ceftizoxime—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.00209	0.00209	CcSEcCtD
Ceftizoxime—Diarrhoea—Cisplatin—urinary bladder cancer	0.00205	0.00206	CcSEcCtD
Ceftizoxime—Erythema multiforme—Epirubicin—urinary bladder cancer	0.00205	0.00205	CcSEcCtD
Ceftizoxime—Vomiting—Gemcitabine—urinary bladder cancer	0.00205	0.00205	CcSEcCtD
Ceftizoxime—Rash—Gemcitabine—urinary bladder cancer	0.00203	0.00203	CcSEcCtD
Ceftizoxime—Dermatitis—Gemcitabine—urinary bladder cancer	0.00203	0.00203	CcSEcCtD
Ceftizoxime—Hypersensitivity—Etoposide—urinary bladder cancer	0.00202	0.00203	CcSEcCtD
Ceftizoxime—Cefdinir—MPO—urinary bladder cancer	0.00202	1	CrCbGaD
Ceftizoxime—Haemoglobin—Doxorubicin—urinary bladder cancer	0.00202	0.00202	CcSEcCtD
Ceftizoxime—Vomiting—Fluorouracil—urinary bladder cancer	0.00201	0.00202	CcSEcCtD
Ceftizoxime—Haemorrhage—Doxorubicin—urinary bladder cancer	0.00201	0.00201	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.002	0.002	CcSEcCtD
Ceftizoxime—Rash—Fluorouracil—urinary bladder cancer	0.00199	0.002	CcSEcCtD
Ceftizoxime—Dermatitis—Fluorouracil—urinary bladder cancer	0.00199	0.002	CcSEcCtD
Ceftizoxime—Pruritus—Etoposide—urinary bladder cancer	0.00194	0.00195	CcSEcCtD
Ceftizoxime—Nausea—Gemcitabine—urinary bladder cancer	0.00191	0.00192	CcSEcCtD
Ceftizoxime—Vomiting—Cisplatin—urinary bladder cancer	0.00191	0.00191	CcSEcCtD
Ceftizoxime—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.0019	0.0019	CcSEcCtD
Ceftizoxime—Rash—Cisplatin—urinary bladder cancer	0.00189	0.00189	CcSEcCtD
Ceftizoxime—Dermatitis—Cisplatin—urinary bladder cancer	0.00189	0.00189	CcSEcCtD
Ceftizoxime—Diarrhoea—Etoposide—urinary bladder cancer	0.00188	0.00188	CcSEcCtD
Ceftizoxime—Nausea—Fluorouracil—urinary bladder cancer	0.00188	0.00188	CcSEcCtD
Ceftizoxime—Anaemia—Methotrexate—urinary bladder cancer	0.00186	0.00187	CcSEcCtD
Ceftizoxime—Leukopenia—Methotrexate—urinary bladder cancer	0.00181	0.00181	CcSEcCtD
Ceftizoxime—Nausea—Cisplatin—urinary bladder cancer	0.00178	0.00179	CcSEcCtD
Ceftizoxime—Convulsion—Methotrexate—urinary bladder cancer	0.00175	0.00175	CcSEcCtD
Ceftizoxime—Vomiting—Etoposide—urinary bladder cancer	0.00175	0.00175	CcSEcCtD
Ceftizoxime—Anaemia—Epirubicin—urinary bladder cancer	0.00174	0.00175	CcSEcCtD
Ceftizoxime—Rash—Etoposide—urinary bladder cancer	0.00173	0.00174	CcSEcCtD
Ceftizoxime—Dermatitis—Etoposide—urinary bladder cancer	0.00173	0.00173	CcSEcCtD
Ceftizoxime—Leukopenia—Epirubicin—urinary bladder cancer	0.00169	0.00169	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.00165	0.00165	CcSEcCtD
Ceftizoxime—Convulsion—Epirubicin—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Ceftizoxime—Nausea—Etoposide—urinary bladder cancer	0.00163	0.00164	CcSEcCtD
Ceftizoxime—Anaemia—Doxorubicin—urinary bladder cancer	0.00161	0.00162	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.00161	0.00161	CcSEcCtD
Ceftizoxime—Leukopenia—Doxorubicin—urinary bladder cancer	0.00156	0.00157	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.00154	0.00154	CcSEcCtD
Ceftizoxime—Convulsion—Doxorubicin—urinary bladder cancer	0.00151	0.00152	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.00151	0.00151	CcSEcCtD
Ceftizoxime—Paraesthesia—Methotrexate—urinary bladder cancer	0.00148	0.00148	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.00143	0.00143	CcSEcCtD
Ceftizoxime—Pain—Methotrexate—urinary bladder cancer	0.00141	0.00141	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.0014	0.0014	CcSEcCtD
Ceftizoxime—Paraesthesia—Epirubicin—urinary bladder cancer	0.00138	0.00139	CcSEcCtD
Ceftizoxime—Pain—Epirubicin—urinary bladder cancer	0.00132	0.00132	CcSEcCtD
Ceftizoxime—Body temperature increased—Methotrexate—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Ceftizoxime—Paraesthesia—Doxorubicin—urinary bladder cancer	0.00128	0.00128	CcSEcCtD
Ceftizoxime—Pain—Doxorubicin—urinary bladder cancer	0.00122	0.00122	CcSEcCtD
Ceftizoxime—Body temperature increased—Epirubicin—urinary bladder cancer	0.00122	0.00122	CcSEcCtD
Ceftizoxime—Hypersensitivity—Methotrexate—urinary bladder cancer	0.00121	0.00122	CcSEcCtD
Ceftizoxime—Pruritus—Methotrexate—urinary bladder cancer	0.00116	0.00117	CcSEcCtD
Ceftizoxime—Hypersensitivity—Epirubicin—urinary bladder cancer	0.00113	0.00114	CcSEcCtD
Ceftizoxime—Body temperature increased—Doxorubicin—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Ceftizoxime—Diarrhoea—Methotrexate—urinary bladder cancer	0.00113	0.00113	CcSEcCtD
Ceftizoxime—Pruritus—Epirubicin—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Ceftizoxime—Diarrhoea—Epirubicin—urinary bladder cancer	0.00105	0.00106	CcSEcCtD
Ceftizoxime—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Ceftizoxime—Vomiting—Methotrexate—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Ceftizoxime—Rash—Methotrexate—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Ceftizoxime—Dermatitis—Methotrexate—urinary bladder cancer	0.00104	0.00104	CcSEcCtD
Ceftizoxime—Pruritus—Doxorubicin—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Ceftizoxime—Vomiting—Epirubicin—urinary bladder cancer	0.000979	0.000981	CcSEcCtD
Ceftizoxime—Nausea—Methotrexate—urinary bladder cancer	0.000978	0.00098	CcSEcCtD
Ceftizoxime—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000975	0.000977	CcSEcCtD
Ceftizoxime—Rash—Epirubicin—urinary bladder cancer	0.000971	0.000973	CcSEcCtD
Ceftizoxime—Dermatitis—Epirubicin—urinary bladder cancer	0.00097	0.000972	CcSEcCtD
Ceftizoxime—Nausea—Epirubicin—urinary bladder cancer	0.000915	0.000917	CcSEcCtD
Ceftizoxime—Vomiting—Doxorubicin—urinary bladder cancer	0.000906	0.000908	CcSEcCtD
Ceftizoxime—Rash—Doxorubicin—urinary bladder cancer	0.000899	0.0009	CcSEcCtD
Ceftizoxime—Dermatitis—Doxorubicin—urinary bladder cancer	0.000898	0.0009	CcSEcCtD
Ceftizoxime—Nausea—Doxorubicin—urinary bladder cancer	0.000846	0.000848	CcSEcCtD
